A Phase II Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Every-21-Day Docetaxel Consolidation in Patients With Inoperable Stage IIIA/B Squamous Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin; Cisplatin
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 23 Nov 2016 Planned number of patients changed from 22 to 54.
- 23 Nov 2016 Planned End Date changed from 1 Apr 2020 to 1 Sep 2020.
- 23 Nov 2016 Planned primary completion date changed from 1 May 2019 to 1 Oct 2019.